Position in RGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,813,344
-$10,798,905 QoQ
Shares Held
1,051,712
-22.8% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 97.80034838434857.ToString("F0")%
Shared 0.ToString("F0")%
None 2.199651615651433.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,242,753 across 213 Biotechnology names. RGNX ranks #44 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in RGNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,813,344 | 1,051,712 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $19,612,249 | 1,361,962 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $12,445,169 | 1,289,655 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $7,636,906 | 930,196 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $4,437,252 | 620,595 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $204,333 | 26,434 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $380,335 | 36,257 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $238,434 | 20,379 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $395,832 | 22,052 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $363,420 | 22,079 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $490,874 | 24,556 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,575,240 | 83,302 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,418,592 | 238,915 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,114,310 | 193,504 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,533,705 | 143,065 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,343,896 | 40,491 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $299,690 | 8,786 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $249,842 | 5,508 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $407,130 | 14,794 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $349,185 | 9,481 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $288,894 | 8,922 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||